Benin vs Burundi: Tuberculosis patients who tested positive for HIV
Benin
495 patients
in 2021
Burundi
387 patients
in 2021
Benin rank
54th
Burundi rank
57th
Tuberculosis patients who tested positive for HIV over time
- Benin
- Burundi
How they compare
Benin currently reports 495 patients against 387 patients in Burundi, a difference of 108 patients.
That makes Benin's figure about 1.3 times Burundi's.
The two have swapped places 4 times across 13 shared years of data; in 2008 it was Benin ahead.
Benin ranks 54th and Burundi ranks 57th of 201 countries.
Across the 3 decades both report, Benin averaged higher in 1 and Burundi in 2.
Head to head by decade
| Decade | Benin | Burundi | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 643 patients | 774 patients | 131 patients | Burundi |
| 2010s | 613.67 patients | 928.44 patients | 314.78 patients | Burundi |
| 2020s | 520.5 patients | 473 patients | 47.5 patients | Benin |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients who tested positive for hiv, Benin or Burundi?
- Benin, at 495 patients against 387 patients in Burundi as of 2021.
- What is the difference in tuberculosis patients who tested positive for hiv between Benin and Burundi?
- 108 patients, with Benin ahead.
- How many years of comparable data are there for Benin and Burundi?
- 13 years are reported by both, from 2008 to 2021.
- How do Benin and Burundi rank globally for tuberculosis patients who tested positive for hiv?
- Benin ranks 54th and Burundi ranks 57th of 201 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients who tested positive for HIV. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of tuberculosis (new and relapsed) patients that tested positive for HIV.